Demographic or Characteristic | MF/F-MDI 200/10 μg BID (n = 371) | FP/S-DPI 250/50 μg BID (n = 351) |
---|---|---|
Sex, n (%) | ||
Female | 239 (64) | 220 (63) |
Race, n (%) | ||
White | 323 (87) | 301 (86) |
Mean age, y (range) | 44.8 (12-82) | 45.1 (12-80) |
Duration of asthma, y | ||
Mean | 15.0 | 15.9 |
Median | 11.0 | 13.0 |
Prior ICS use, n (%)* | 225 (61) | 188 (54) |
Prior ICS/LABA use, n (%)* | ||
Budesonide/formoterol | 59 (16) | 59 (17) |
Fluticasone/salmeterol | 104 (28) | 115 (33) |
Mean FEV1 at baseline | ||
L | 2.30 | 2.37 |
Percentage predicted | 73.8 | 74.4 |
Mean total ACQ score† | 1.80 | 1.80 |
Mean total AQLQ(S) score‡ | 5.14 | 5.14 |